Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in India evaluating brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine for adults with Hodgkin lymphoma; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brentuximab vedotin (Brentuximab vedotin)
  • Dacarbazine (dacarbazine)
  • Doxorubicin (doxorubicin)
  • Vinblastine (vinblastine)

Snippet

Sponsor: Takeda | Conditions: Hodgkin Lymphoma | Phase 4 | Status: RECRUITING